Ascentage Pharma Group International (AAPG)
NASDAQ: AAPG · Real-Time Price · USD
0.00
0.00 (0.00%)
No quote available

AAPG Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Year Ending
TTM Dec '23 Dec '22
Cash & Equivalents
1,1001,0941,492
Cash & Cash Equivalents
1,1001,0941,492
Cash Growth
--26.70%-
Receivables
-145.8954.36
Inventory
-16.179.45
Other Current Assets
-88.2980.44
Total Current Assets
-1,3441,636
Property, Plant & Equipment
-905.82602.09
Long-Term Investments
-18.95371.35
Goodwill and Intangibles
-161.39155.63
Other Long-Term Assets
-70.0664.71
Total Long-Term Assets
-1,1561,194
Total Assets
-2,5002,830
Accounts Payable
-279.36335.59
Deferred Revenue
-38.4124.35
Current Debt
-616.4518.38
Other Current Liabilities
-02.82
Total Current Liabilities
-934.17881.15
Long-Term Debt
-1,1791,274
Other Long-Term Liabilities
-316.4266.11
Total Long-Term Liabilities
-1,4961,540
Total Liabilities
-2,4302,422
Total Debt
1,7001,7961,793
Debt Growth
-0.16%-
Retained Earnings
--5,365-4,439
Shareholders' Equity
776.4470.63408.66
Net Cash / Debt
-599.78-701.76-300.49
Working Capital
-410.01755.34
Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).